Filing Details
- Accession Number:
- 0001209191-18-048785
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-29 16:02:35
- Reporting Period:
- 2018-08-27
- Accepted Time:
- 2018-08-29 16:02:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1337553 | Aerie Pharmaceuticals Inc | AERI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216984 | A Thomas Mitro | C/O Aerie Pharmaceuticals, Inc. 4301 Emperor Blvd., Suite 400 Durham NC 27703 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-27 | 182,668 | $3.15 | 234,147 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 7,332 | $3.15 | 241,479 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-27 | 189,549 | $60.27 | 51,930 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-27 | 451 | $61.01 | 51,479 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2018-08-27 | 182,668 | $0.00 | 182,668 | $3.15 |
| Common Stock | Option (Right to Buy) | Disposition | 2018-08-27 | 7,332 | $0.00 | 7,332 | $3.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 126,984 | 2017-08-05 | 2023-08-26 | No | 4 | M | Direct |
| 63,498 | 2017-08-05 | 2023-09-12 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold pursuant to the reporting person's Rule 10b5-1 plan in multiple transactions at prices ranging from $60.00 to $60.95, inclusive.
- The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 3 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold pursuant to the reporting person's Rule 10b5-1 plan in multiple transactions at prices ranging from $61.00 to $61.05, inclusive.
Billionaire Hedge Funds
